This is an old revision of this page, as edited by Quantumobserver (talk | contribs) at 07:05, 24 December 2013 (+Category:Medicine; +Category:Geriatrics using HotCat). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
 | This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (December 2013) |
This article is a stub. You can help Wikipedia by expanding it. |
Pseudohypoxia refers to increased cytosolic ratio of free NADH to NAD in cells[1]
Research has shown that declining NAD+ during aging causes pseudohypoxia, and that raising nuclear NAD+ in old mice reverses pseudohypoxia and metabolic dysfunction, thus reversing the ageing process[2]. It is expected that human NAD trials will begin in 2014 [3]
